4//SEC Filing
Meckler Jeffrey A 4
Accession 0001641172-25-021376
CIK 0001857044other
Filed
Jul 28, 8:00 PM ET
Accepted
Jul 29, 4:15 PM ET
Size
7.8 KB
Accession
0001641172-25-021376
Insider Transaction Report
Form 4
Meckler Jeffrey A
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2025-07-27$8.30/sh+6,068$50,379→ 13,312 total - Award
Common Stock Warrants
2025-07-27$8.30/sh+12,136$100,758→ 16,688 totalExercise: $8.30From: 2025-07-27Exp: 2030-07-27→ Common Stock (12,136 underlying)
Footnotes (1)
- [F1]The Reporting Person acquired 6,068 shares of common stock and 12,136 warrants to purchase common stock from the Issuer following the mandatory conversion of a convertible note that the Reporting Person acquired from the Issuer in a private placement in June 2025 at a conversion price of $8.3024, which is equal to 80% of the average closing price of the Issuer's shares of common stock on the Nasdaq Capital Market for the five trading days immediately preceding and including the conversion date of July 27, 2025.
Documents
Issuer
Indaptus Therapeutics, Inc.
CIK 0001857044
Entity typeother
Related Parties
1- filerCIK 0001506916
Filing Metadata
- Form type
- 4
- Filed
- Jul 28, 8:00 PM ET
- Accepted
- Jul 29, 4:15 PM ET
- Size
- 7.8 KB